Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention · 2025
Influence of cannabis and alcohol on motor vehicle injury severity in Canadian trauma centres: a prospective study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Simmons Sarah M, Donoghue Madison, Erdelyi Shannon, Chan Herbert, Vaillancourt Christian, Atkinson Paul, Besserer Floyd, Clarke David B, Davis Phil, Daoust Raoul, Émond Marcel, Eppler Jeffrey, Lee Jacques S, MacPherson Andrew, Magee Kirk, Mercier Eric, Ohle Robert, Parsons Michael, Rao Jagadish, Rowe Brian H, Taylor John, Wishart Ian, Brubacher Jeffrey R
Аннотация
BACKGROUND: Alcohol and delta-9-tetrahydrocannabinol (THC) (main impairing ingredient of cannabis) are both crash contributors that interfere with motor vehicle operation. However, the relationship between drug concentration and crash injury severity is unclear for either drug. We aim to clarify the relationship between blood alcohol concentration (BAC) and crash injury severity, based on healthcare system utilisation, with and without THC.
METHODS: The National Drug Driving Study is an ongoing prospective study involving 17 Canadian trauma centres. Eligible subjects included drivers aged 16+ who visited a participating trauma centre and had blood drawn as part of routine care within 6 hours of a crash. Deidentified blood samples were tested for alcohol and THC using gas chromatography-flame ionisation detection and liquid chromatography/tandem mass spectrometry. Study outcomes included admission to hospital and admitted patients' length of hospital stay.
RESULTS: 10 322 injured drivers visited a participating trauma centre between 2018 and 2023. 1649 (16.0%), 1716 (16.6%) and 463 (4.5%) drivers had detectable levels of alcohol, THC or both, respectively. Compared with sober drivers (BAC=0), drivers with 0%<BAC<0.08% had increased odds of admission (aOR=1.69, 95% CI=1.31 to 2.19), as did drivers with BAC≥0.08% (aOR=1.36, 95% CI=1.16 to 1.60). THC did not modify the relationship between alcohol and admission. Neither alcohol nor THC predicted were associated with length of stay following admission.
INTERPRETATION: Alcohol increases hospital admissions after crashes but does not have a dose-response relationship with admission or length of stay. THC does not moderate this relationship.
METHODS: The National Drug Driving Study is an ongoing prospective study involving 17 Canadian trauma centres. Eligible subjects included drivers aged 16+ who visited a participating trauma centre and had blood drawn as part of routine care within 6 hours of a crash. Deidentified blood samples were tested for alcohol and THC using gas chromatography-flame ionisation detection and liquid chromatography/tandem mass spectrometry. Study outcomes included admission to hospital and admitted patients' length of hospital stay.
RESULTS: 10 322 injured drivers visited a participating trauma centre between 2018 and 2023. 1649 (16.0%), 1716 (16.6%) and 463 (4.5%) drivers had detectable levels of alcohol, THC or both, respectively. Compared with sober drivers (BAC=0), drivers with 0%<BAC<0.08% had increased odds of admission (aOR=1.69, 95% CI=1.31 to 2.19), as did drivers with BAC≥0.08% (aOR=1.36, 95% CI=1.16 to 1.60). THC did not modify the relationship between alcohol and admission. Neither alcohol nor THC predicted were associated with length of stay following admission.
INTERPRETATION: Alcohol increases hospital admissions after crashes but does not have a dose-response relationship with admission or length of stay. THC does not moderate this relationship.